NASDAQ : HELP
Cybin Inc. — Financial statements
Healthcare · Biotechnology · Canada
Last price 10.71 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 782.47M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 43.01M | 45.14M | 32.63M | 24.07M | 15.77M | 22.61M |
| Research & Development | 102.35M | 86.59M | 39.21M | 23.90M | 18.84M | 14.09M |
| Operating Expenses | 167.04M | 142.59M | 103.12M | 58.22M | 38.08M | 51.13M |
| Operating Income | -167.04M | -142.59M | -103.12M | -58.22M | -38.08M | -51.13M |
| Interest Expense | -2.92M | |||||
| Interest & Investment Income | 5.43M | 5.10M | 5.99M | 457.12K | 445.67K | 193.04K |
| Currency Exchange Gain (Loss) | -1.47M | 492.00K | 15.55M | 101.17K | 2.98M | -247.50K |
| Other Non Operating Income (Expenses) | -7.00K | 22.00K | -20.00K | |||
| EBT Excluding Unusual Items | -163.10M | -139.89M | -81.61M | -57.66M | -34.65M | -51.19M |
| Gain (Loss) on Sale of Investments | -192.16K | -23.23K | ||||
| Gain (Loss) on Sale of Assets | 7.00K | 7.00K | ||||
| Other Unusual Items | -8.12M | -8.12M | -252.77K | -2.96M | ||
| Pretax Income | -171.20M | -148.00M | -81.61M | -57.66M | -35.10M | -54.17M |
| Net Income | -171.20M | -148.00M | -81.61M | -57.66M | -35.10M | -54.17M |
| Net Income to Common | -171.20M | -148.00M | -81.61M | -57.66M | -35.10M | -54.17M |
| Shares Outstanding (Basic) | 42.28M | 34.80M | 20.22M | 8.30M | 4.88M | 4.40M |
| Shares Outstanding (Diluted) | 42.28M | 34.80M | 20.22M | 8.30M | 4.88M | 4.40M |
| EPS (Basic) | -4.05 | -4.25 | -4.04 | -6.95 | -7.19 | -12.30 |
| EPS (Diluted) | -4.05 | -4.25 | -4.04 | -6.95 | -7.30 | -12.30 |
| Free Cash Flow | -140.76M | -133.46M | -72.35M | -50.90M | -35.16M | -36.29M |
| Free Cash Flow Per Share | -3.33 | -3.83 | -3.58 | -6.13 | -7.20 | -8.24 |
| EBITDA | -166.94M | -142.47M | -102.80M | -58.03M | -37.90M | -51.00M |
| D&A For EBITDA | 109.00K | 116.00K | 329.00K | 192.01K | 172.21K | 134.57K |
| EBIT | -167.04M | -142.59M | -103.12M | -58.22M | -38.08M | -51.13M |
Balance sheet
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 166.37M | 157.26M | 93.92M | 154.34M | 12.29M | 42.97M |
| Cash & Short-Term Investments | 166.37M | 157.26M | 93.92M | 154.34M | 12.29M | 42.97M |
| Other Receivables | 5.04M | 5.03M | 4.09M | 3.31M | 2.25M | 1.68M |
| Receivables | 5.04M | 5.03M | 4.09M | 3.31M | 2.25M | 1.68M |
| Prepaid Expenses | 21.29M | 22.24M | 15.41M | 2.13M | 1.28M | 1.02M |
| Other Current Assets | 2.02M | 1.61M | 1.31M | 1.07M | ||
| Total Current Assets | 192.69M | 184.52M | 115.45M | 161.39M | 17.14M | 46.74M |
| Property, Plant & Equipment | 180.00K | 195.00K | 98.00K | 403.95K | 332.59K | 393.29K |
| Long-Term Investments | 193.84K | |||||
| Goodwill | 36.24M | 36.23M | 35.81M | 35.06M | 18.32M | 18.34M |
| Other Intangible Assets | 30.54M | 30.22M | 28.53M | 26.19M | 4.04M | 1.67M |
| Total Assets | 259.65M | 251.17M | 179.90M | 223.04M | 39.83M | 67.33M |
| Accounts Payable | 17.44M | 17.99M | 14.90M | 7.24M | 4.19M | 4.21M |
| Current Portion of Leases | 214.90K | |||||
| Other Current Liabilities | 1.38M | 2.12M | ||||
| Total Current Liabilities | 17.57M | 19.38M | 14.90M | 7.46M | 4.19M | 6.33M |
| Total Liabilities | 17.57M | 19.38M | 14.90M | 7.46M | 4.19M | 6.33M |
| Common Stock | 538.87M | 492.10M | 345.31M | 327.80M | 116.90M | 113.30M |
| Additional Paid-In Capital | 50.68M | 34.97M | 32.63M | 8.68M | 1.55M | 420.52K |
| Retained Earnings | -437.35M | -389.54M | -255.39M | -167.07M | -109.50M | -80.63M |
| Comprehensive Income & Other | 89.89M | 94.25M | 42.46M | 46.18M | 26.70M | 27.91M |
| Shareholders' Equity | 242.09M | 231.79M | 165.00M | 215.58M | 35.65M | 61.00M |
| Total Liabilities & Equity | 259.65M | 251.17M | 179.90M | 223.04M | 39.83M | 67.33M |
| Total Debt | 214.90K | |||||
| Net Cash (Debt) | 166.37M | 157.26M | 93.92M | 154.12M | 12.29M | 42.97M |
| Net Cash Per Share | 3.93 | 4.52 | 4.64 | 18.57 | 2.52 | 9.76 |
| Filing Date Shares Outstanding | 73.06M | 61.98M | 23.03M | 20.00M | 5.62M | 4.64M |
| Total Common Shares Outstanding | 61.98M | 51.63M | 21.61M | 20.00M | 5.28M | 4.61M |
| Working Capital | 175.13M | 165.15M | 100.55M | 153.93M | 12.95M | 40.41M |
| Book Value Per Share | 3.91 | 4.49 | 7.63 | 10.78 | 6.75 | 13.24 |
| Tangible Book Value | 175.31M | 165.34M | 100.65M | 154.33M | 13.28M | 40.99M |
| Tangible Book Value Per Share | 2.83 | 3.20 | 4.66 | 7.71 | 2.52 | 8.89 |
| Machinery | 820.00K | 811.00K | 687.00K | 686.79K | 667.40K | 571.10K |
Cash flow statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -171.20M | -148.00M | -81.61M | -57.66M | -35.10M | -54.17M |
| Depreciation & Amortization | 109.00K | 116.00K | 329.00K | 295.39K | 172.21K | 134.57K |
| Other Amortization | 4.00K | 4.00K | 19.00K | 17.72K | 13.30K | |
| Loss (Gain) From Sale of Assets | -7.00K | |||||
| Asset Writedown & Restructuring Costs | 13.29K | |||||
| Loss (Gain) From Sale of Investments | 192.16K | 23.23K | ||||
| Stock-Based Compensation | 21.68M | 10.86M | 31.28M | 10.25M | 3.46M | 14.44M |
| Other Operating Activities | 6.97M | 5.01M | -15.53M | -95.27K | -2.74M | 3.19M |
| Change in Accounts Receivable | -933.00K | -934.00K | -790.00K | -804.21K | -700.66K | -619.16K |
| Change in Accounts Payable | 3.02M | 4.48M | 7.66M | -1.88M | 296.38K | 1.98M |
| Change in Other Net Operating Assets | -439.00K | -4.80M | -13.70M | -1.03M | -657.79K | -1.19M |
| Operating Cash Flow | -140.79M | -133.27M | -72.33M | -50.89M | -35.06M | -36.21M |
| Capital Expenditures | 34.00K | -188.00K | -26.00K | -15.51K | -104.95K | -84.10K |
| Sale of Property, Plant & Equipment | 10.00K | |||||
| Cash Acquisitions | 5.64M | |||||
| Sale (Purchase) of Intangibles | -1.50M | -1.19M | -1.37M | -508.82K | -2.34M | -332.41K |
| Investment in Securities | -200.25K | |||||
| Investing Cash Flow | -1.46M | -1.36M | -1.40M | 5.11M | -2.45M | -616.76K |
| Long-Term Debt Issued | 44.50M | |||||
| Long-Term Debt Repaid | -20.15M | -210.00K | -110.03K | |||
| Lease Payments | -210.00K | -110.03K | ||||
| Net Debt Issued (Repaid) | -20.15M | 24.35M | -210.00K | -110.03K | ||
| Issuance of Common Stock | 191.95M | 155.55M | 15.32M | 200.37M | 10.73M | 31.06M |
| Repurchase of Common Stock | -75.00K | -75.00K | ||||
| Other Financing Activities | 18.42M | 18.42M | -1.02M | -12.31M | -702.14K | -2.40M |
| Financing Cash Flow | 190.14M | 198.24M | 14.10M | 187.95M | 10.03M | 28.66M |
| Foreign Exchange Rate Adjustments | -211.00K | -269.00K | -687.00K | -119.64K | 124.17K | -148.18K |
| Net Cash Flow | 47.67M | 63.34M | -60.32M | 142.05M | -27.35M | -8.32M |
| Free Cash Flow | -140.76M | -133.46M | -72.35M | -50.90M | -35.16M | -36.29M |
| Free Cash Flow Per Share | -3.33 | -3.83 | -3.58 | -6.13 | -7.20 | -8.24 |
| Levered Free Cash Flow | -82.43M | -82.59M | -41.03M | -25.49M | -25.61M | -17.20M |
| Unlevered Free Cash Flow | -82.43M | -80.76M | -41.03M | -25.49M | -25.61M | -17.20M |
| Free Cash Flow After Leases | -140.76M | -133.46M | -72.56M | -51.01M | -35.16M | -36.29M |
| Cash Interest Paid | 5.50M | 5.50M | ||||
| Change in Working Capital | 1.64M | -1.26M | -6.82M | -3.71M | -1.06M | 170.61K |
Ratios
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 642.93M | 240.17M | 133.37M | 314.33M | 75.82M | 141.74M |
| Enterprise Value | 476.56M | 45.04M | 38.65M | 285.08M | 59.10M | 91.50M |
| Last Close Price | 8.80 | 4.80 | 6.34 | 15.71 | 14.63 | 31.05 |
| PB Ratio | 2.25 | 1.04 | 0.81 | 1.46 | 2.13 | 2.32 |
| P/TBV Ratio | 3.67 | 1.45 | 1.32 | 2.04 | 5.71 | 3.46 |
| Debt / Equity Ratio | 0.00 | |||||
| Net Debt / Equity Ratio | -0.69 | -0.68 | -0.57 | -0.71 | -0.34 | -0.70 |
| Net Debt / EBITDA Ratio | 1.00 | 1.10 | 0.91 | 2.66 | 0.32 | 0.84 |
| Net Debt / FCF Ratio | 1.18 | 1.18 | 1.30 | 3.03 | 0.35 | 1.18 |
| Quick Ratio | 9.76 | 8.38 | 6.58 | 21.14 | 3.48 | 7.05 |
| Current Ratio | 10.97 | 9.52 | 7.75 | 21.65 | 4.09 | 7.38 |
| Return on Equity (ROE) | -86.94% | -74.60% | -44.34% | -45.91% | -76.36% | -83.35% |
| Return on Assets (ROA) | -44.38% | -41.35% | -33.05% | -27.69% | -46.68% | -45.29% |
| Return on Capital Employed (ROCE) | -69.00% | -61.50% | -62.50% | -27.00% | -106.80% | -83.80% |
| Earnings Yield | -46.01% | -61.62% | -61.19% | -18.34% | -46.29% | -38.22% |
| FCF Yield | -21.89% | -55.57% | -54.25% | -16.19% | -46.37% | -25.61% |
| Buyback Yield / Dilution | -103.06% | -72.10% | -143.72% | -70.01% | -10.85% | -67.27% |